Inhaled corticosteroids (ICS) are commonly prescribed for chronic obstructive pulmonary disease (COPD), but not recommended ...

The FDA approved Amgen's Uplizna as the first treatment for IgG4-RD. The decision is backed by the MITIGATE trial, showing reduced flares and sustained efficacy.

The FDA has approved Fabhalta (iptacopan) for the treatment of adults with complement 3 glomerulopathy (C3G), to reduce proteinuria.

The International League of Dermatological Societies (ILDS) has raised concerns about the misuse of topical corticosteroids ...

Hormonal acne can appear in adolescents and adults. There are multiple contributing factors, especially excess androgens.

For patients with chronic obstructive pulmonary disorder (COPD), long-term inhaled corticosteroid (ICS) treatment is ...

Coronation Street star says she has incurable condition that’s ‘getting worse every day’ - Vitiligo is a skin condition ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...

Among patients with previous sinus surgery for chronic rhinosinusitis with nasal polyps, the number of past surgeries did not ...

The following is a summary of “Plasma pharmacometabolomics of inhaled corticosteroid-related adrenal suppression in asthma,” published in the March 2025 issue of Journal of Allergy and Clinical ...

Afrin and Flonase are over-the-counter nasal sprays. Learn how they compare in effectiveness, side effects, and safety to ...